Core Viewpoint - A class action lawsuit has been filed against uniQure N.V. concerning allegations of securities fraud and unlawful business practices [2]. Group 1: Lawsuit Details - The lawsuit involves claims that uniQure and certain officers and/or directors engaged in securities fraud or other unlawful business practices [2]. - Investors have until April 13, 2026, to request to be appointed as Lead Plaintiff if they purchased or acquired uniQure securities during the Class Period [2]. Group 2: Company Developments - On November 3, 2025, uniQure announced feedback from the U.S. FDA regarding its investigational gene therapy AMT-130 for Huntington's disease, indicating a shift in the FDA's stance on the adequacy of data from Phase I/II studies for a Biologics License Application (BLA) submission [4]. - Following this announcement, uniQure's stock price dropped by $33.40 per share, or 49.34%, closing at $34.29 per share on the same day [4].

Core Viewpoint - Levi & Korsinsky, LLP has announced a class action securities lawsuit on behalf of Coupang, Inc. investors, alleging securities fraud related to inadequate cybersecurity protocols and failure to report a data breach [1] Group 1: Lawsuit Details - The lawsuit seeks to recover losses for Coupang, Inc. investors affected by alleged securities fraud between May 7, 2025, and December 16, 2025 [1] - The complaint alleges that Coupang had inadequate cybersecurity measures that allowed a former employee to access sensitive customer information for nearly six months without detection [1] - It is claimed that the company faced a materially heightened risk of regulatory and legal scrutiny due to this breach [1] Group 2: Reporting and Compliance Issues - The defendants allegedly failed to report the data breach in a timely manner as required by U.S. Securities and Exchange Commission (SEC) reporting rules [1] - The public statements made by the defendants were claimed to be materially false and/or misleading during the relevant time period [1] Group 3: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until February 17, 2026, to request to be appointed as lead plaintiff [1] - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [1] Group 4: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [1]

Core Viewpoint - A class action lawsuit has been filed against Paysafe Limited (PSFE) for securities fraud, following disappointing financial results and undisclosed risks related to its business operations [1] Financial Performance - Paysafe reported Q3 2025 revenue of $433.8 million, missing consensus estimates by $5.8 million - The company experienced a net loss of $87.7 million, a significant increase from a net loss of $12.98 million in the same period the previous year - Full year 2025 expected revenue was revised down to $17 million at the midpoint, with adjusted EPS at $0.50 at the midpoint [1] Key Issues Revealed - The company disclosed a credit loss expense of $13,220, primarily due to expected chargebacks related to a specific merchant - Write-offs amounted to $9,924, driven by irrecoverable amounts in the Merchant Solutions segment - CEO Bruce Lowthers indicated that a last-minute client shutdown led to several million-dollar write-downs in Q3 and mentioned challenges with higher risk Merchant Category Codes [1] Allegations in the Lawsuit - The lawsuit alleges that Paysafe made materially false and misleading statements and failed to disclose adverse facts about its business - Specific allegations include significant exposure to a high-risk client, understated credit loss reserves, and undisclosed issues with Merchant Category Codes - The lawsuit claims these issues negatively impacted revenue growth and made it unlikely for Paysafe to meet its previously issued financial guidance for fiscal year 2025 [1]

Core Viewpoint - Guangdong Jushi Chemical Co., Ltd. (stock code: 688669) has been penalized by the China Securities Regulatory Commission (CSRC) for violations related to information disclosure, specifically for inflating revenue, costs, and profits through fictitious trade activities [2][6]. Group 1: Violations and Penalties - The CSRC found that Jushi Chemical and its subsidiaries engaged in fictitious trade activities, including controlling companies that conducted trades without actual goods, resulting in inflated revenue of approximately 156.81 million yuan, inflated costs of about 158.47 million yuan, and a reduced profit of around 1.66 million yuan, which represented 8.32%, 8.51%, and 6.81% of total revenue, costs, and profit respectively for the first half of 2023 [2][6]. - The CSRC has ordered Jushi Chemical and its responsible personnel to rectify the situation, issued warnings, and imposed fines [2][6]. Group 2: Legal Implications for Investors - Investors who suffered losses due to Jushi Chemical's actions can seek civil compensation, which includes investment differences, commissions, and stamp duties, as per the Civil Code and Securities Law [3][7]. - A lawyer has initiated a campaign to collect claims from investors who purchased Jushi Chemical's securities between August 29, 2023, and November 21, 2025, and either sold or continued to hold them after November 22, 2025 [8][7]. Group 3: Claim Registration Requirements - Investors wishing to register claims must provide specific documents, including a copy of their ID, original securities account confirmation, and transaction records stamped by their brokerage [9].

Core Viewpoint - Varonis Systems, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 4, 2025, and October 28, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Varonis provided misleading positive statements while concealing adverse facts about its ability to convert its customer base to its SaaS offering, leading to reduced Annual Recurring Revenue (ARR) growth potential [2] - On October 28, 2025, Varonis reported third-quarter financial results that significantly missed ARR expectations and lowered its full-year guidance, attributing this to weaker than expected renewals and conversions in its subscription business [2] - Following the announcement, Varonis' stock price plummeted from $63.00 per share to $32.34 per share on October 29, 2025, marking a decline of approximately 48.67% in one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until March 9, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Core Points - A securities fraud class action lawsuit has been filed against CoreWeave, Inc. (NASDAQ: CRWV) for alleged material misstatements and omissions during the class period from March 28, 2025, to December 15, 2025 [1] - The lead plaintiff deadline for affected investors is set for March 13, 2026 [1] - Allegations include overstating the company's ability to meet customer demand and underestimating risks associated with reliance on a single third-party data center supplier, which could negatively impact revenue [1] Affected Investors - The lawsuit is on behalf of those who purchased or acquired CoreWeave securities during the specified class period [1] - Investors are encouraged to contact Kessler Topaz Meltzer & Check, LLP for assistance in recovering investment losses [1] Legal Process - Investors may seek to be appointed as lead plaintiff representatives or remain absent class members, with the lead plaintiff typically being the one with the largest financial interest [1] - The law firm Kessler Topaz Meltzer & Check, LLP specializes in securities-fraud class actions and has a history of significant recoveries in securities litigation [1]

Core Points - A class action securities lawsuit has been filed against CoreWeave, Inc. for alleged securities fraud affecting investors between March 28, 2025, and December 15, 2025 [1] - The lawsuit claims that CoreWeave's management overstated the company's ability to meet customer demand and downplayed risks associated with reliance on a single third-party data center supplier, which could negatively impact revenue [2] - Investors who suffered losses during the specified period have until March 13, 2026, to request to be appointed as lead plaintiff, with no out-of-pocket costs for class members to participate [3] Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders and being recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4]

Core Viewpoint - A class action securities lawsuit has been filed against Fermi Inc. due to alleged securities fraud affecting investors who purchased shares during the company's initial public offering and subsequent period [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who acquired Fermi Inc. common stock during its October 2025 IPO and between October 1, 2025, and December 11, 2025 [2]. - The complaint alleges that Fermi Inc. made false statements regarding tenant demand for its Project Matador campus and the reliance on a single tenant's funding commitment, which posed a significant risk of termination [3]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until March 6, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - Ramaco Resources, Inc. is facing a class action lawsuit due to allegations of securities fraud related to misleading statements about its Brook Mine operations, which were claimed to be non-existent or exaggerated during the specified class period [1]. Group 1: Lawsuit Details - The class action lawsuit is filed on behalf of investors who purchased Ramaco securities between July 31, 2025, and October 23, 2025 [1]. - The lawsuit alleges that Ramaco made materially false and misleading statements regarding the commencement and progress of mining activities at the Brook Mine [1]. - The report from Wolfpack Research claims that no significant mining activity occurred at the Brook Mine after its groundbreaking, leading to a significant drop in Ramaco's stock price by $3.81, or 9.6%, to close at $36.01 per share on October 23, 2025 [1]. Group 2: Allegations Against the Company - The lawsuit claims that Ramaco failed to disclose that no active work was taking place at the Brook Mine, which misled investors about the company's operational status [1]. - It is alleged that the company overstated development progress at the Brook Mine, which contributed to the misleading nature of its positive statements about business prospects [1]. - The lawsuit emphasizes that the defendants' statements lacked a reasonable basis, further compounding the misleading information provided to investors [1].

Core Viewpoint - F5, Inc. is facing a class action lawsuit due to a significant security breach that has adversely affected its stock price and investor confidence [1][5]. Company Events - On October 15, 2025, F5 disclosed a security breach involving unauthorized access by a sophisticated nation-state threat actor, which led to the exfiltration of sensitive files, including portions of the BIG-IP source code [2]. - Following this announcement, F5's stock price dropped by $35.40, or 10.7%, closing at $295.35 per share on October 16, 2025, resulting in investor losses [2]. - On October 27, 2025, F5 reported its fourth quarter fiscal 2025 results, projecting low growth expectations for fiscal 2026 due to the security breach, which would lead to reduced sales, elongated sales cycles, and increased expenses for remediation efforts [3]. - The stock price fell further by $22.83, or 7.8%, closing at $267.58 per share on October 28, 2025, compounding investor injuries [4]. Lawsuit Details - The class action lawsuit alleges that F5's management made materially false and misleading statements regarding the company's business and failed to disclose the significant security incident, which posed risks to its clientele and future prospects [5]. - The lawsuit claims that the positive statements made by F5's management lacked a reasonable basis and were misleading throughout the class period [5]. - Investors who acquired F5 securities during the class period are encouraged to file a lead plaintiff motion by February 17, 2026 [6].